Attention Biotech Investors: February PDUFA Catalysts Come Calling By: Benzinga via Benzinga January 31, 2018 at 15:30 PM EST Although the action was light on the FDA approval front, biotech stocks took the spotlight in January, thanks to a few ... Read More >> Related Stocks: Amag Pharmaceuticals Antares Pharma Apricus Biosc Inc Celgene Corp Gilead Sciences Gsk Plc ADR Kempharm Inc Nasdaq Biotechnology Ishares ETF Pacira Pharm Inc S&P Biotech SPDR Sanofi-Aventis S.A. ADR Sorrento Therapeutics Inc Valeant Pharmaceuticals International, Inc. Vertex Pharmaceuticals